MAPK3 and hepatocellular carcinoma: The increase in ERK1/2 activation upon rOSM stimulation of LIF-05-treated hepatoma cells (Fig. 3C, lane 10) indicated that the OSMR offers higher affinity binding sites for the activation of this MAPK pathway compared to the LIFR.